Cargando…
Evolution of randomized, controlled studies of medical therapy in chronic thromboembolic pulmonary hypertension
Although pulmonary endarterectomy (PEA) is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), many patients have inoperable disease, and some have persistent or recurrent pulmonary hypertension (PH) after surgery. Alternative options (balloon pulmonary angioplasty (BP...
Autores principales: | Kim, Nick H., Papamatheakis, Demosthenes G., Fernandes, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150542/ https://www.ncbi.nlm.nih.gov/pubmed/34104419 http://dx.doi.org/10.1177/20458940211007373 |
Ejemplares similares
-
Letter to the Editor regarding “Could pulmonary arterial hypertension patients be at lower risk from severe COVID-19?”
por: Fernandes, Timothy M., et al.
Publicado: (2020) -
Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019) -
Outcomes of cardiopulmonary resuscitation in patients with pulmonary arterial hypertension
por: Yang, Jenny Z., et al.
Publicado: (2022) -
Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
por: Wu, Sheryl, et al.
Publicado: (2022) -
The pathophysiology of chronic thromboembolic pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2017)